A new identity for ORMALVI, a treatment for Primary Periodic Paralysis (PPP), a rare genetic disorder that causes sudden episodes of extreme muscle weakness, stiffness and temporary paralysis.
As part of an ongoing relationship with Cycle Pharmaceuticals, I designed the brand and guidelines for ORMALVI, a treatment for Primary Periodic Paralysis (PPP), a rare genetic disorder that causes sudden episodes of extreme muscle weakness, stiffness and temporary paralysis. The project included brand, guidelines, website design and supporting materials.